Holdings
CapForce IBD 50 ETF
As of Jul 31, 2026, CapForce IBD 50 ETF reported 50 positions worth US$79.4M. Largest: Kiniksa Pharmaceuticals International, Plc, Guardant Health, Inc. and Travere Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | 45,359 | US$3.37M | new | Jul 31, 2026 |
| Guardant Health, Inc. | 18,787 | US$3.04M | new | Jul 31, 2026 |
| Travere Therapeutics, Inc. | 50,342 | US$2.81M | −24,192 | Jul 31, 2026 |
| Tg Therapeutics, Inc. | 53,762 | US$2.8M | new | Jul 31, 2026 |
| Enova International, Inc. | 10,910 | US$2.77M | new | Jul 31, 2026 |
| Liquidia Corporation | 32,539 | US$2.74M | +21,020 | Jul 31, 2026 |
| Okeanis Eco Tankers Corp. | 42,990 | US$2.59M | −7,666 | Jul 31, 2026 |
| Oscar Health, Inc. | 82,292 | US$2.57M | new | Jul 31, 2026 |
| Sezzle Inc. | 16,254 | US$2.52M | new | Jul 31, 2026 |
| Carpenter Technology Corporation | 4,819 | US$2.5M | new | Jul 31, 2026 |